These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25845294)

  • 1. Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome.
    Picard C; Burtey S; Bornet C; Curti C; Montana M; Vanelle P
    Pathol Biol (Paris); 2015 Jun; 63(3):136-43. PubMed ID: 25845294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).
    Caillaud C; Zaloszyc A; Licht C; Pichault V; Frémeaux-Bacchi V; Fischbach M
    Pediatr Nephrol; 2016 Jan; 31(1):157-61. PubMed ID: 26399238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
    Mahat U; Matar RB; Rotz SJ
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27913. PubMed ID: 31286658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eculizumab in severe Shiga-toxin-associated HUS.
    Lapeyraque AL; Malina M; Fremeaux-Bacchi V; Boppel T; Kirschfink M; Oualha M; Proulx F; Clermont MJ; Le Deist F; Niaudet P; Schaefer F
    N Engl J Med; 2011 Jun; 364(26):2561-3. PubMed ID: 21612462
    [No Abstract]   [Full Text] [Related]  

  • 6. Posttransplant recurrence of atypical hemolytic uremic syndrome.
    Valoti E; Alberti M; Noris M
    J Nephrol; 2012; 25(6):911-7. PubMed ID: 22760880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hemolytic uremic syndrome.
    Loirat C; Saland J; Bitzan M
    Presse Med; 2012 Mar; 41(3 Pt 2):e115-35. PubMed ID: 22284541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement Gene Variants and Shiga Toxin-Producing
    Frémeaux-Bacchi V; Sellier-Leclerc AL; Vieira-Martins P; Limou S; Kwon T; Lahoche A; Novo R; Llanas B; Nobili F; Roussey G; Cailliez M; Ulinski T; Deschênes G; Alberti C; Weill FX; Mariani P; Loirat C
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):364-377. PubMed ID: 30674459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome in children.
    Talarico V; Aloe M; Monzani A; Miniero R; Bona G
    Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections.
    Serna A; Boedeker EC
    Curr Opin Gastroenterol; 2008 Jan; 24(1):38-47. PubMed ID: 18043231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic Uremic Syndrome.
    Cody EM; Dixon BP
    Pediatr Clin North Am; 2019 Feb; 66(1):235-246. PubMed ID: 30454746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HUS and the case for complement.
    Conway EM
    Blood; 2015 Oct; 126(18):2085-90. PubMed ID: 26396094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
    Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
    Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.
    Giordano P; Netti GS; Santangelo L; Castellano G; Carbone V; Torres DD; Martino M; Sesta M; Di Cuonzo F; Resta MC; Gaeta A; Milella L; Chironna M; Germinario C; Scavia G; Gesualdo L; Giordano M
    Pediatr Nephrol; 2019 Mar; 34(3):517-527. PubMed ID: 30362078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
    Kielstein JT; Beutel G; Fleig S; Steinhoff J; Meyer TN; Hafer C; Kuhlmann U; Bramstedt J; Panzer U; Vischedyk M; Busch V; Ries W; Mitzner S; Mees S; Stracke S; Nürnberger J; Gerke P; Wiesner M; Sucke B; Abu-Tair M; Kribben A; Klause N; Schindler R; Merkel F; Schnatter S; Dorresteijn EM; Samuelsson O; Brunkhorst R;
    Nephrol Dial Transplant; 2012 Oct; 27(10):3807-15. PubMed ID: 23114903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Escherichia coli associated hemolytic and uremic syndrome: what lessons can be learned after the European epidemic of 2011?].
    Lemaignen A; Ridel C; Hertig A; Rondeau E
    Nephrol Ther; 2013 Jun; 9(3):129-36. PubMed ID: 23266201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.
    Schwarz C; Brehon A; Mousseaux C; Luque Y; Senet P; Mariani P; Mohamadou I; Zafrani L; Frémeaux-Bacchi V; Rondeau E; Buob D; Rafat C
    BMC Nephrol; 2020 Jul; 21(1):269. PubMed ID: 32652955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed.
    Karpman D
    Nephrol Dial Transplant; 2012 Oct; 27(10):3669-74. PubMed ID: 23114892
    [No Abstract]   [Full Text] [Related]  

  • 19. Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics.
    Petruzziello-Pellegrini TN; Marsden PA
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):433-40. PubMed ID: 22660553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.
    Braune SA; Wichmann D; von Heinz MC; Nierhaus A; Becker H; Meyer TN; Meyer GP; Müller-Schulz M; Fricke J; de Weerth A; Hoepker WW; Fiehler J; Magnus T; Gerloff C; Panzer U; Stahl RA; Wegscheider K; Kluge S
    Crit Care Med; 2013 Jul; 41(7):1702-10. PubMed ID: 23660733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.